Site: 119 — New London, Connecticut

Site: 119 is a clinical research site located in New London, Connecticut, United States 06320.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site: 119 has participated in 1 clinical trials.

Therapeutic areas: Diabetic Peripheral Neuropathy, Pain.

Sponsors: Astellas Pharma Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New London

Browse all research sites in Connecticut · View every site in New London

• Lawrence + Memorial Hospital ED (L&M), YNHHS
• Lawrence and Memorial Hospital
• Lawrence + Memorial Hospital
• Yale New Haven Health Lawrence & Memorial Hospital
• Coastal Connecticut Research
• Research SIte
• New England Retina Associates
• Pfizer Investigational Site
• Retina Group of New England
• Psychiatric Medicine Center
• Novartis Investigative Site
• BioSante Site 151

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site: 119?

Site: 119 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site: 119 conducted?

Site: 119 has 1 clinical trials on record. Their work covers Diabetic Peripheral Neuropathy, Pain.

Is Site: 119 accredited by Crixeo Clinical Trials?

Site: 119 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site: 119?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.